Cancer Research - Invidious

Cancer Research

Dana-Farber Cancer Institute | 264 videos | Updated 2 months ago

View playlist on YouTube | Switch Invidious Instance

Dana-Farber is as dedicated to discoveries in cancer research as it is to delivering compassionate, patient-centered care. We support scientific leaders and young investigators, acquire technology at the leading edge of cancer research, and ensure a spirit of collaboration and innovation. Learn about recent cancer research breakthroughs and discover how Dana-Farber's scientists are leading the way in the fight against cancer. You can learn more about Dana-Farber's research advances on our website: www.dana-farber.org/Research.aspx

2:41

ASH24: Shai Shimony, MD, MPH & H. Moses Murdoch, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

3:29

ASH24: Jacqueline Garcia, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:36

Kidney cancer research: Belzutifan versus everolimus | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

3:11

CAR T cell therapy and infection prevention | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:12

What is Targeted Protein Degradation?

Dana-Farber Cancer Institute

2:19

ONS Congress 2024: Jenny Spencer, RN, BSN | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:00

ONS Congress 2024: Linda Ramsdell, MSN, FNP-BC | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:27

ONS Congress 2024: Ludmila Svoboda, RN, MSN | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:23

ONS Congress 2024: Jacqueline Tuskan, MSN, RN | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:10

ONS Congress 2024: Marilyn Hammer, PhD, RN | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:04

AACR24: Cami Christopher, MPH, Survivorship | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:37

AACR24: Rebecca Porter, MD, Endometrial Cancer | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:32

AACR24: Pasi Janne, MD, PhD, Lung Cancer | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:22

ASH23: Corey Cutler, MD, MPH, on AGAVE-201 | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

3:25

SABCS23: Nolan Priedigkeit, MD, PhD on RNA fusions in breast cancer | Dana-Farber Caner Institute

Dana-Farber Cancer Institute

2:08

SABCS23: Heather Parsons, MD, MPH, discusses liquid biopsy | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:10

SABCS23: Paolo Tarantino, MD, discusses RELIEVE study | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:57

SABCS23: Kate Dibble, PhD, discusses ovarian function suppression | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:09

ASH23: Andrew Hantel, MD, discusses artificial intelligence | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:39

ASH23: Paul Richardson, MD, discusses MEZI trial | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:44

ASH23: Shai Shimony, MD, molecular ontogeny in AML | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:58

ASH23: Elizabeth Lightbody, PhD, potential markers multiple myeloma | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:52

ASH23: Corey Cutler, MD, MPH, on GVHD and stem cell transplant | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:22

ASH23: Reid Merryman, MD, on ct-DNA & diffuse large B-cell lymphoma | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:11

ASH23: Katie Maurer, MD, PhD, on immune system features and CAR-T | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:01

ASH23: Shayna Sarosiek, MD, neuropathy in MGUS or Waldenstrom macroglobulinemia | Dana-Farber Cancer

Dana-Farber Cancer Institute

1:43

ASH23: Jennifer Brown, MD, PhD, discusses ALPINE trial | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:31

ASH23: Omar Nadeem, MD, discusses Immuno-PRISM trial | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:47

ASH23: Andrew Hantel, MD, discusses clinical trial disparities | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:29

Stem cell transplant recipient meets donor | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:34

Glioblastoma INSIGhT Trial | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:32

Lung cancer research at World Lung Cancer Conference | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:35

Negative studies | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:50

Artificial Intelligence to diagnose muscle wasting | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:45

Muscle wasting as a sign of pancreatic cancer | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:25

ASCO23: Patrick Wen, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:45

ASCO23: Sara Tolaney, MD, MPH | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:25

ASCO23: Paolo Tarantino, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:32

ASCO23: Praful Ravi, MB BCHIR, MRCP | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:26

ASCO23: Jia Luo, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:41

ASCO23: Glenn Hanna, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:51

ASCO23: Jennifer Ligibel, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:12

ASCO23: Toni Choueiri, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:50

Multiple Myeloma: Study identifies genes as potential targets | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:07

Technology helping older patients with cancer | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:58

AACR23: Harry Klein, PhD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:58

AACR23: James Lindsay, PhD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:30

AACR23: Ursula Matulonis, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:30

AACR23: Harsh Singh, MBBS | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:56

Ursula Matulonis, MD - Society for Gynecologic Oncology 2023 | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:43

ASCO GU 23 Penile Cancer Research | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:29

ASCO GU23 Treatment-free survival in kidney cancer | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:08

ASCO GU23 CheckMate-9ER Biomarker Analysis: Toni Choueiri, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:19

ASCO GU23 Triplet therapy in kidney cancer: Toni Choueiri, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:22

ASCO GU23 Toni Choueiri, MD: CheckMate-9ER 3-year follow-up | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:01

ASCO GU23 Toni Choueiri, MD: KEYNOTE-564 subgroup analysis | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:42

ASCO GU23 Paul Nguyen, MD: FORMULA-509 | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:34

What is Graft Versus Host Disease? | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:33

COVID Booster and Cancer | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:28

Multiple Myeloma precursor clinical trial helps patient | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:09

Machine learning and end-of-life care | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:52

ASCO GI23: Muhammet Ozer, MD, on liver cancer metastasis | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:47

ASCO GI23: Muhammet Ozer, MD, on Race/Ethnicity in liver cancer | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:38

Cancer and COVID-19: High risk patients | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:15

Kidney cancer research: follow-up on immunotherapy after surgery | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:53

Colorectal cancer mutation research | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:27

Esophageal cancer research advances | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:03

ESMO22: Ben Schlechter, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:01

ESMO22: Toni Choueiri, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:43

ESMO22: Glenn Hanna, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:28

ESMO22: Breast cancer research by Sara Tolaney, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:18

ESMO22: Breast cancer research by Sara Tolaney, MD (TROPiCS) | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:25

ESMO22: Catherine Marinac, PhD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:13

Prostate Cancer: New treatment offers hope | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:34

Sexual health in women with lung cancer | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:37

COVID-19: Clinical trials bounce back after significant disruption | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:40

Multiple Myeloma Research: Risks, benefits of stem cell transplant | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:11

Colorectal cancer gene mutations | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:48

Kidney cancer research supports immunotherapy | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:48

ASCO22: Breast cancer research by Meredith Regan, ScD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:55

ASCO22: Glioblastoma research by David Reardon, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:27

ASCO22: Lung Cancer session by Jia Luo, MD

Dana-Farber Cancer Institute

1:50

ASCO22: Breast cancer research by Chris Labaki, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:15

ASCO22: Chris Manz, MD on AI in oncology | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:30

ASCO22: Pasi Janne, MD, PhD on lung cancer research | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:43

ASCO22: Marla Lipsyc-Sharf, MD on ctDNA in breast cancer | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:06

ASCO22: Breast cancer research by Sara Tolaney, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:50

ASCO22: Kidney Cancer research by Toni Choueiri, MD | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:29

Lynch Syndrome: Know your risk | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:56

Rare Cancer: Immunotherapy in genitourinary cancer | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:57

Bladder Cancer Research: Multiplexed autoantibody profiling | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:17

Bladder Cancer Research: Metabolomic plasma profiling | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:25

Bladder Cancer Research: Immunotherapy outcomes | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:14

COVID-19 and Genitourinary Cancer: Pandemic's impact | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:30

Kidney Cancer Research: Immunotherapy after surgery | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:30

Prostate Cancer Research: Mapping the patient journey | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:39

ASCO #GI22: Immunotherapy and Colorectal Cancer Research

Dana-Farber Cancer Institute

2:14

Translocation Renal Cell Carcinoma Research

Dana-Farber Cancer Institute

2:29

Bladder Cancer: New study in preoperative treatment

Dana-Farber Cancer Institute

1:35

COVID-19 and Cancer: Breakthrough Infections

Dana-Farber Cancer Institute

2:26

FDA approval offers hope for prevention of acute graft-versus-host disease

Dana-Farber Cancer Institute

1:59

Kidney Cancer: New immunotherapy treatment after surgery

Dana-Farber Cancer Institute

2:29

Pancreatic Cancer: Advances in treatment and detection

Dana-Farber Cancer Institute

2:18

Stem Cell Transplant: Advances in graft v. host disease

Dana-Farber Cancer Institute

2:11

Kidney Cancer: Drug shows activity in brain metastases

Dana-Farber Cancer Institute

2:03

Precision Oncology: New research looks at integrative molecular profiles

Dana-Farber Cancer Institute

2:14

Stem cell transplant beneficial for older patients with myelodysplastic syndrome

Dana-Farber Cancer Institute

1:23

Bladder cancer research at ESMO 2021

Dana-Farber Cancer Institute

1:56

Lung cancer research at ESMO 2021

Dana-Farber Cancer Institute

2:22

Kidney cancer research at ESMO 2021

Dana-Farber Cancer Institute

1:19

Breast cancer research at ESMO 2021

Dana-Farber Cancer Institute

2:24

Personalized cancer vaccine helps patient

Dana-Farber Cancer Institute

2:25

COVID-19 and Cancer: Screenings rebound but study finds disparities

Dana-Farber Cancer Institute

2:07

Red meat linked to colorectal cancer development

Dana-Farber Cancer Institute

2:16

Ovarian cancer screening: Simple blood test shows promise

Dana-Farber Cancer Institute

1:24

ASCO21: Kevin Campbell, MD, presents neuroblastoma research

Dana-Farber Cancer Institute

2:10

ASCO21: Alison Schwartz, MS, LGC, presents on genetic variants misattributed to Li-Fraumeni syndrome

Dana-Farber Cancer Institute

1:22

ASCO21: Ann S. LaCasce, MD, MMSc presents study on PET adapted therapy in classic Hodgkin lymphoma

Dana-Farber Cancer Institute

2:01

ASCO21: Pasi A. Jänne, MD, PhD, highlights lung cancer research

Dana-Farber Cancer Institute

2:20

Kidney Cancer: Immunotherapy after surgery

Dana-Farber Cancer Institute

1:55:29

2021 Living with EGFR-Mutant Lung Cancer: A Virtual Forum for Patients and Caregivers

Dana-Farber Cancer Institute

2:19

Colorectal Cancer Screening: 45 is the new 50

Dana-Farber Cancer Institute

1:43

Bile Duct Cancer Research from Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

2:17

Covid-19 Vaccine Study in Cancer Patients

Dana-Farber Cancer Institute

1:51

Kidney Cancer Research: HIF-2α Inhibition

Dana-Farber Cancer Institute

2:13

Multiple Myeloma: Grandmother living active life after CAR-T treatment

Dana-Farber Cancer Institute

2:33

Addressing Cancer Inequities

Dana-Farber Cancer Institute

2:21

Kidney Cancer and Immune System Dysfunction

Dana-Farber Cancer Institute

2:22

Bladder Cancer Advances | ASCO GU21

Dana-Farber Cancer Institute

2:36

Kidney Cancer Research: FDA approves immunotherapy combination

Dana-Farber Cancer Institute

2:48

Cancer Research: FDA approves CAR T-cell therapy for indolent follicular lymphoma

Dana-Farber Cancer Institute

2:16

Dana-Farber Research: Treatment resistance in prostate cancer

Dana-Farber Cancer Institute

2:42

A Patient's Journey with EGFR Mutant Lung Cancer

Dana-Farber Cancer Institute

1:56

Rectal Cancer Research: Highlights from ASCO GI

Dana-Farber Cancer Institute

2:11

COVID-19: Study shows sharp decline in cancer screenings and diagnoses

Dana-Farber Cancer Institute

1:22

Dana-Farber Cancer Institute: Reid Merryman, MD ASH 2020

Dana-Farber Cancer Institute

0:52

Dana-Farber Cancer Institute: Christopher Gibson, MD ASH 2020

Dana-Farber Cancer Institute

1:39

Dana-Farber Cancer Institute: Corey Cutler, MD ASH 2020

Dana-Farber Cancer Institute

1:07

Dana-Farber Cancer Institute: Annamaria Gulla, MD ASH 2020

Dana-Farber Cancer Institute

1:19

Dana-Farber Cancer Institute: Jennifer Crombie, MD ASH 2020

Dana-Farber Cancer Institute

1:31

Dana-Farber Cancer Institute: Marlise Luskin, MD ASH 2020

Dana-Farber Cancer Institute

1:13

Dana-Farber Cancer Institute: Andrew Lane, MD at ASH 2020

Dana-Farber Cancer Institute

1:27

Dana-Farber Cancer Institute: Vincent Ho, MD ASH 2020

Dana-Farber Cancer Institute

1:32

Dana-Farber Cancer Institute: Oreofe Odejide, MD ASH 2020

Dana-Farber Cancer Institute

1:21

Dana-Farber Cancer Institute: Roman Shapiro, MD ASH 2020

Dana-Farber Cancer Institute

1:31

Dana-Farber Cancer Institute: Caron Jacobson, MD ASH 2020

Dana-Farber Cancer Institute

2:47

Advances in Lymphoma: A patient's journey

Dana-Farber Cancer Institute

1:25

Racial disparities after cancer surgery

Dana-Farber Cancer Institute

2:15

Liver Cancer: New research at Dana-Farber

Dana-Farber Cancer Institute

2:00

Cancer genetics: Using machine-learning in prostate cancer and melanoma

Dana-Farber Cancer Institute

2:15

COVID-19 and Cancer: New study looks at COVID-19 in individuals at high risk for multiple myeloma

Dana-Farber Cancer Institute

1:33

Association of Medicaid Expansion and Cancer Mortality

Dana-Farber Cancer Institute

2:23

Dana-Farber research looks at blood test to detect cancer

Dana-Farber Cancer Institute

3:14

Breast Cancer - A Patient's Journey with Inflammatory Breast Cancer: Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:59

COVID-19 and Cancer: Current Challenges and Perspectives

Dana-Farber Cancer Institute

2:09

COVID-19 and cancer clinical trials: Dana-Farber Cancer Institute case study

Dana-Farber Cancer Institute

1:52

Breast Cancer Research at ESMO 20: Erica L. Mayer, MD, MPH

Dana-Farber Cancer Institute

2:01

Breast Cancer Research at ESMO 20: Elizabeth Ann Mittendorf, MD, PhD

Dana-Farber Cancer Institute

1:21

Prostate Cancer Research at ESMO 2020: Christopher Sweeney, MBBS

Dana-Farber Cancer Institute

1:38

Kidney Cancer Research at ESMO 2020: Toni Choueiri, MD

Dana-Farber Cancer Institute

1:42

Is coffee consumption good for advanced colon cancer?

Dana-Farber Cancer Institute

2:16

Reimagining Immunotherapy in Head and Neck Cancer: Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:52

Prostate Cancer Research: Is there a future for immunotherapy?

Dana-Farber Cancer Institute

2:18

New research in acute myeloid leukemia

Dana-Farber Cancer Institute

2:03

Dana Farber's Dr. George Demetri honored with Karnofsky award

Dana-Farber Cancer Institute

2:07

Hodgkin lymphoma: new research by Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

1:33

CAR T-cell therapy approved for mantle cell lymphoma

Dana-Farber Cancer Institute

1:38

Prostate cancer research links spread of disease to epigenetics

Dana-Farber Cancer Institute

2:01

Biomarker Test Highly Accurate in Detecting Early Kidney Cancer

Dana-Farber Cancer Institute

2:14

Prostate Cancer Research: Launching a study during the COVID-19 pandemic

Dana-Farber Cancer Institute

1:38

Kidney Cancer (papillary renal cell carcinoma) research presented by Dana-Farber at ASCO 20

Dana-Farber Cancer Institute

2:07

Multiple Myeloma research presented by Dana-Farber at ASCO 20

Dana-Farber Cancer Institute

1:28

Kidney Cancer research presented by Dana-Farber at ASCO 20

Dana-Farber Cancer Institute

2:15

Ovarian Cancer research presented by Dana-Farber at ASCO 2020

Dana-Farber Cancer Institute

2:13

Lung Cancer research presented by Dana-Farber at ASCO 2020

Dana-Farber Cancer Institute

2:12

Genetic Counseling/Prostate Cancer research presented by Dana-Farber at ASCO 20

Dana-Farber Cancer Institute

2:19

Colon Cancer research presented by Dana-Farber at ASCO 2020

Dana-Farber Cancer Institute

1:55

CAR-T research from Dana-Farber in follicular lymphoma and marginal zone lymphoma

Dana-Farber Cancer Institute

1:39

Kidney Cancer Research: Immunotherapy Combinations in Rare Kidney Cancers

Dana-Farber Cancer Institute

2:34

Colorectal Cancer in young adults: A patient's story

Dana-Farber Cancer Institute

2:21

Pancreatic Cancer: new treatment and research opportunities

Dana-Farber Cancer Institute

2:50

Cancer patient living longer thanks to work of Nobel laureate

Dana-Farber Cancer Institute

2:00

ASH 2019: Improving global lymphoma diagnoses

Dana-Farber Cancer Institute

1:27

Dana-Farber Town Hall: Message from William G. Kaelin, MD, Nobel Laureate

Dana-Farber Cancer Institute

2:01

Dana-Farber's William Kaelin wins Nobel Prize

Dana-Farber Cancer Institute

2:32

Breast Cancer Research: A Focus on Older Women

Dana-Farber Cancer Institute

1:57

Lymphoma chemotherapy drug also acts as immunotherapy, new research finds

Dana-Farber Cancer Institute

2:21

Cancer patients partner with researchers in "Count Me In" projects

Dana-Farber Cancer Institute

1:36

Cancer researcher recognized for work in precision medicine

Dana-Farber Cancer Institute

1:29

Cancer Research: Immunotherapy combination shows promise in kidney cancer

Dana-Farber Cancer Institute

2:21

How immunotherapy might be effective for triple-negative breast cancer

Dana-Farber Cancer Institute

1:53

Dana-Farber researchers win Grand Challenge

Dana-Farber Cancer Institute

1:28

Immunotherapy and Bladder Cancer

Dana-Farber Cancer Institute

1:46

Center for Protein Degradation at Dana-Farber

Dana-Farber Cancer Institute

2:09

Trial aims to treat kidney cancer tumor before surgery

Dana-Farber Cancer Institute

2:10

Obesity, Women, and Colorectal Cancer

Dana-Farber Cancer Institute

2:05

Expanded treatment options for Acute Myeloid Leukemia (AML)

Dana-Farber Cancer Institute

1:46

Myeloma: Immune response may predict progression

Dana-Farber Cancer Institute

2:09

Improving outcomes for myeloid cancers

Dana-Farber Cancer Institute

35:26

What’s New in Cancer Genetics? | Dana-Farber Cancer Institute

Dana-Farber Cancer Institute